Agenus (AGEN) Operating Expenses (2010 - 2026)
Agenus (AGEN) posted quarterly Operating Expenses of $18.7 million for Q1 2026, down 50.02% year-over-year from $37.4 million in Q1 2025, and down 5.68% quarter-over-quarter from $19.8 million in Q4 2025.
Agenus (AGEN) Operating Expenses (2010 - 2026) Analysis & Trends
Agenus' Operating Expenses history runs 17 years deep, the most recent figure standing at $18.7 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 50.02% year-over-year to $18.7 million; the TTM figure through Mar 2026 stood at $115.2 million (down 43.54% YoY), while the FY2025 annual figure was $20000.0, down 79.38% from the prior year.
- Operating Expenses for Q1 2026 stood at $18.7 million, down from $19.8 million in the prior quarter.
- The five-year high for Operating Expenses was $78.3 million in Q4 2022, with the low at -$300000.0 in Q4 2023.
- The 5-year median for Operating Expenses is $39.8 million (2025), against an average of $36.7 million.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses tumbled 100.38% in 2023, then jumped 24038.29% in 2024.
- Agenus' Operating Expenses stood at $78.3 million in 2022, then sank by 100.38% to -$300000.0 in 2023, then surged by 18335.33% to $54.7 million in 2024, then slumped by 63.8% to $19.8 million in 2025, then decreased by 5.68% to $18.7 million in 2026.
- Business Quant data shows AGEN's Operating Expenses at $18.7 million in Q1 2026, $19.8 million in Q4 2025, and $34.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Agenus | 311.95 Mn | 286.43 Mn | 34.52 Mn | 23.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.23 Mn |
| Mar 31, 2026 | 18.68 Mn |
| Dec 31, 2025 | 19.81 Mn |
| Sep 30, 2025 | 34.46 Mn |
| Jun 30, 2025 | 42.23 Mn |
| Mar 31, 2025 | 37.38 Mn |
| Dec 31, 2024 | 54.71 Mn |
| Sep 30, 2024 | 58.33 Mn |
| Jun 30, 2024 | 53.59 Mn |
| Mar 31, 2024 | 450,000.00 |
| Dec 31, 2023 | -300,000.00 |
| Jun 30, 2023 | 222,000.00 |
| Mar 31, 2023 | 228,000.00 |
| Dec 31, 2022 | 78.32 Mn |
| Sep 30, 2022 | 64.12 Mn |
| Jun 30, 2022 | 63.87 Mn |
| Mar 31, 2022 | 61.40 Mn |
| Dec 31, 2021 | 75.46 Mn |
| Sep 30, 2021 | 64.32 Mn |
| Jun 30, 2021 | 62.16 Mn |